- 商品介绍
- 规格参数
- 包装参数
Application
Pemafibrate may be used in research studies tostudy its effects on lipid metabolism, inflammation, and cardiovascular health.
Biochem/physiol Actions
Pemafibrate is an orally active, highly potent and selective peroxisome proliferator-activated receptor alpha (PPARα) agonist (hPPAR EC50 = 1 nM/α, 1.10 μM/γ, 1,58 μM/δ by cell-based reporter assays using respective transfectants). When administered in vivo Pemafibrate is >100-fold more effective than fenofibrate in lowering triglyceride (TG) in normal rats (1 mg/kg p.o.) and in increasing HDL-cholesterol (HDL-C) in human apoA-I (h-apoA-I) transgenic mice (3 mg/kg p.o.). Compared to other fibrates, pemafibrate′s distinct Y-shaped structure aids in stronger PPAR-α activation, better lipid binding, greater potency, and adaptability to structural changes caused by binding of coactivators. Pemafibrate shows anti-inflammatory activities like lowering the levels of interleukin-6, tumor necrosis factor-α, monocyte chemoattractant protein-1, vascular cell adhesion molecule-1 (VCAM-1), macrophage marker F4/80). It also exhibits antiatherogenic effects by lowering the levels of certain factors such as plasma triglycerides (TG), TG-rich lipoproteins, and apolipoprotein C-III (apoC-III), and increases lipoprotein lipase (LPL) activity and high-density lipoprotein (HDL) levels. Pemafibrate promotes fibroblast growth factor 21 and contributes to the reduction of insulin resistance.
| Quality Level | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | -10 to -25°C |
| SMILES string | COC(C=C1)=CC=C1OCCCN(CC2=CC(O[C@H](CC)C(O)=O)=CC=C2)C3=NC4=C(O3)C=CC=C4 |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
¥ 1596.77
-
¥ 1451.54
-
询价
-
询价
-
询价
-
¥ 8520.40
-
询价
-
询价
-
¥ 2307.00
-
¥ 1476.00
-
¥ 1749.15
-
¥ 1586.69
-
¥ 3404.94
-
¥ 4476.05
-
¥ 14985.93
-
¥ 17652.29
-
¥ 29754.56
-
询价
-
¥ 55311.07
-
¥ 3704.60
微信小程序
7X24小时在线咨询